Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 06-2020 | 12-2019 | 06-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,258 | 144,841 | 227,233 | 167,899 | 179,883 |
| Marketable Securities | 16,957 | 17,837 | 17,895 | 17,510 | 17,971 |
| Receivables | 24,918 | 17,560 | 20,989 | 58,138 | 179,644 |
| Other current assets | 0 | 0 | 1 | -1 | 0 |
| TOTAL | $198,133 | $180,238 | $266,118 | $243,546 | $377,498 |
| Non-Current Assets | |||||
| Investments And Advances | 44,474 | 40,600 | 41,446 | 39,700 | 41,549 |
| Other Non-Current Assets | 95,204 | 132,210 | 128,889 | 100,215 | 101,775 |
| TOTAL | $139,678 | $172,810 | $170,335 | $139,915 | $143,324 |
| Total Assets | $351,169 | $366,739 | $449,524 | $396,272 | $532,886 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,447 | 2,241 | 2,386 | 1,936 | 1,591 |
| Accounts payable and accrued liabilities | 33,742 | 29,228 | 55,444 | 31,678 | 108,245 |
| Other current liabilities | 15,772 | 59,200 | 78,611 | 72,660 | 122,511 |
| TOTAL | $51,961 | $90,670 | $136,441 | $106,273 | $232,346 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,356 | 18,478 | 18,584 | 3,638 | 3,750 |
| Other Non-Current Liabilities | 56,261 | 4,864 | 4,370 | 12,298 | 17,011 |
| TOTAL | $121,036 | $47,302 | $69,577 | $86,252 | $103,028 |
| Total Liabilities | $172,998 | $137,971 | $206,018 | $192,529 | $335,376 |
| Shareholders' Equity | |||||
| Common Shares | 4,512 | 4,345 | 4,414 | 3,600 | 3,776 |
| Retained earnings | -251,832 | -182,841 | -174,352 | -136,758 | -159,188 |
| Other shareholders' equity | 406 | -627 | -527 | -2,130 | -1,298 |
| TOTAL | $178,171 | $228,769 | $243,506 | $203,743 | $197,510 |
| Total Liabilities And Equity | $351,169 | $366,740 | $449,524 | $396,272 | $532,886 |